共 95 条
[1]
Ang TL(2014)Clinical epidemiology of gastric cancer Singapore Med J 55 621-628
[2]
Fock KM(2020)Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies Int J Mol Sci 21 4012-1237
[3]
Machlowska J(2019)The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis Gastric Cancer 22 1226-89
[4]
Baj J(2019)Predictors of survival outcome following radical gastrectomy for gastric cancer ANZ J Surg 89 84-5410
[5]
Sitarz M(2017)Progress in the treatment of advanced gastric cancer Tumour Biol 39 1010428317714626-2387
[6]
Rau B(2014)Role of epithelial-mesenchymal transition in gastric cancer initiation and progression World J Gastroenterol 20 5403-1114
[7]
Brandl A(2020)Inhibition or reversal of the epithelial-mesenchymal transition in gastric cancer: pharmacological approaches Int J Mol Sci 22 277-17
[8]
Thuss-Patience P(2017)Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer J Exp Clin Cancer Res 36 19-1847
[9]
Lui SA(2015)Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis Oncol Lett 9 2381-608
[10]
Tan WB(2020)Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity Arch Biochem Biophys 689 108413-133